Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Naphthazarin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021 1 0
Ginkgolic acid C17:1 Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Ginkgo biloba leaves extract Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Anacardic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 2 0
Sciadopitysin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 6 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Reduning Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021 1 0
Sargassum horneri polysaccharide extract Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021 1 0